Product Details
Product Name:
PKR-IN-C51 |
CAS No.:
1314594-23-4 |
Purity:
98.94% |
Supply Ability:
10g |
Release date:
2025/05/16 |
Product Introduction
Bioactivity
Name | PKR-IN-C51 |
Description | PKR-IN-C51 is a dose-dependent and ATP-competitive protein kinase R (PKR) inhibitor that inhibits intracellular PKR activation and autophosphorylation in mouse macrophages with an IC50=9 μM and Ki=3.4 μM.Interferon-induced double-stranded RNA-activated protein kinase (PKR) is a widely expressed Ser/Thr kinase. |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 100 mg/mL (272.15 mM), Sonication and heating are recommended.
|
Keywords | PKRINC-51 | PKR-IN-C-51 | PKR-IN-C51 | PKRINC 51 |
Inhibitors Related | Fasudil | Piceatannol | Chymotrypsin | Fasudil hydrochloride | Camostat mesylate | SRPIN340 | HA-1004 | 6-(Dimethylamino)purine | FOY 251 | BMT-124110 Formate | Benzamidine hydrochloride | Cetraxate hydrochloride |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:2283420-62-0
$1520.00 / 25mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$74.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |
|
$74.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |
|
$0.00/1g |
VIP1Y
|
Wuhan Circle Star Chem-medical Technology Co.,Ltd
|
2025-01-17 |